AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33742478 — intervention group
Group type: COMPARATOR
Intervention: Clinically trained providers (family welfare workers, FWWs) providing injectable contraception services
Number of subjects: 460
Study 36371421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (small and bouncing)
Number of subjects: 84
Study 36371421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (small and non-bouncing)
Number of subjects: 84
Study 36371421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (large and bouncing)
Number of subjects: 84
Study 36371421 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 (large and non-bouncing)
Number of subjects: 84
Study 36371421 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84
Study 32743919 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength-based intervention (14 weekly group sessions and 2 bi-weekly follow-up calls)
Number of subjects: 372
Study 32743919 — intervention group
Group type: COMPARATOR
Intervention: Dementia education program (control intervention)
Number of subjects: 372
Study 34791160 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted therapy (including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, mineralocorticoid receptor antagonists, and cardiac rehabilitation)
Number of subjects: 216
Study 34791160 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 216
Study 34791160 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted therapy
Number of subjects: 216
Study 33605807 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 14802
Study 33605807 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher 25OHD levels
Number of subjects: 14802
Study 33605807 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity lowering 25OHD levels
Number of subjects: 14802
Study 33605807 — intervention group
Group type: COMPARATOR
Intervention: Adiponectin
Number of subjects: 14802
Study 33605807 — intervention group
Group type: COMPARATOR
Intervention: Leptin
Number of subjects: 14802
Study 35014961 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative mHealth
Number of subjects: 32
Study 35014961 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 32
Study 32538012 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 151
Study 32538012 — intervention group
Group type: COMPARATOR
Intervention: Peridural blockage
Number of subjects: 151
Study 34089637 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening for 30 minutes post-surgery
Number of subjects: 56
Study 34089637 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 56
Study 32798144 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined everolimus plus lanreotide therapy
Number of subjects: 250
Study 32798144 — intervention group
Group type: COMPARATOR
Intervention: Everolimus monotherapy
Number of subjects: 250
Study 35589429 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based prehabilitation program plus nutritional guidance
Number of subjects: 204
Study 35589429 — intervention group
Group type: COMPARATOR
Intervention: Standard care plus written advice on age-appropriate activity and nutrition
Number of subjects: 204
Study 35589429 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based prehabilitation program plus nutritional guidance (with ≥80% adherence)
Number of subjects: 204
Study 35589429 — intervention group
Group type: COMPARATOR
Intervention: Standard care plus written advice on age-appropriate activity and nutrition (with ≥80% adherence)
Number of subjects: 204
Study 33296541 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (GCBT) plus usual care (UC)
Number of subjects: 0
Study 33296541 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 33881692 — intervention group
Group type: EXPERIMENTAL
Intervention: FYM + P'K'
Number of subjects: 0
Study 33881692 — intervention group
Group type: EXPERIMENTAL
Intervention: FYM + P'K' + L
Number of subjects: 0
Study 33881692 — intervention group
Group type: EXPERIMENTAL
Intervention: NPK + L
Number of subjects: 0
Study 33881692 — intervention group
Group type: EXPERIMENTAL
Intervention: FYM
Number of subjects: 0
Study 33881692 — intervention group
Group type: COMPARATOR
Intervention: NPK
Number of subjects: 0
Study 33881692 — intervention group
Group type: COMPARATOR
Intervention: Unfertilized control
Number of subjects: 0
Study 33253251 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain patients
Number of subjects: 7165
Study 35364018 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg subcutaneously every 4 weeks for 48 weeks
Number of subjects: 150
Study 35364018 — intervention group
Group type: COMPARATOR
Intervention: Placebo subcutaneously every 4 weeks for 48 weeks
Number of subjects: 150
Study 35364018 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 150
Study 35364018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 33376150 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2798745 (2.4 mg)
Number of subjects: 16
Study 33376150 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2798745 (5 mg)
Number of subjects: 16
Study 33376150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 33486061 — intervention group
Group type: EXPERIMENTAL
Intervention: Point Union Bridge (PUB) technique
Number of subjects: 88
Study 33486061 — intervention group
Group type: COMPARATOR
Intervention: Double-row suture bridge (DRSB) technique
Number of subjects: 88
Study 32361032 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Family Therapy (ET)
Number of subjects: 62
Study 32361032 — intervention group
Group type: COMPARATOR
Intervention: Standard cognitive behavioral therapy (CBT) family intervention (ST)
Number of subjects: 62
Study 35549544 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge and Attitudes Toward Hospice and Palliative Care (KAHP) scale
Number of subjects: 0
Study 35549544 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis
Number of subjects: 0
Study 35549544 — intervention group
Group type: EXPERIMENTAL
Intervention: Content validation by ten experts
Number of subjects: 0
Study 35549544 — intervention group
Group type: COMPARATOR
Intervention: Pragmatic, randomized control trial
Number of subjects: 0
Study 33063249 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 0
Study 33063249 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 0
Study 32295569 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Play in ASP intervention
Number of subjects: 456
Study 32295569 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 456
Study 616361154 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 209
Study 616361154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 36178519 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid rapid maxillary expander (RME) and facemask (FM) treatment
Number of subjects: 27
Study 33199379 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg/mL added to LIA mixture
Number of subjects: 140
Study 33199379 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9% added to LIA mixture
Number of subjects: 140
Study 32441415 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of interleukin-1 receptor antagonist (IL-1ra)
Number of subjects: 12577
Study 32441415 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of interleukin-2 receptor alpha subunit (IL-2rα)
Number of subjects: 12577
Study 35409959 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitator group
Number of subjects: 66
Study 35409959 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 66
Study 35409959 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 66
Study 34684626 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Low-Fat (HLF) diet
Number of subjects: 609
Study 34684626 — intervention group
Group type: COMPARATOR
Intervention: Healthy Low-Carbohydrate (HLC) diet
Number of subjects: 609
Study 33326198 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic group
Number of subjects: 60
Study 33326198 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 60
Study 36134648 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus chemotherapy (S + CT group)
Number of subjects: 331
Study 36134648 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 331
Study 36134648 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus oral chemotherapy (S + CT group)
Number of subjects: 331
Study 36134648 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus intravenous chemotherapy (S + CT group)
Number of subjects: 331
Study 36134648 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (S + CT group)
Number of subjects: 331
Study 36134648 — intervention group
Group type: COMPARATOR
Intervention: Matched groups (S + CT vs S)
Number of subjects: 331
Study 34033625 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery training with 85% of one repetition maximum (85%1RM)
Number of subjects: 30
Study 34033625 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery training with optimum power loads (OPL)
Number of subjects: 30
Study 34033625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional MI sessions)
Number of subjects: 30
Study 34941035 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support combined with insulin therapy
Number of subjects: 64
Study 34941035 — intervention group
Group type: COMPARATOR
Intervention: Insulin therapy (Control)
Number of subjects: 64
Study 32572776 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (0.5 mg, daily) and Fuzheng Huayu Tablet (1.6 g, 3 times a day)
Number of subjects: 700
Study 32572776 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (0.5 mg, daily) and Fuzheng Huayu Tablet placebo (1.6 g, 3 times a day)
Number of subjects: 700
Study 33105376 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric jump training (PJT)
Number of subjects: 24
Study 33105376 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONG)
Number of subjects: 24
Study 616874270 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-I
Number of subjects: 106
Study 616874270 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment
Number of subjects: 106
Study 34132704 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane anesthesia
Number of subjects: 460
Study 34132704 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 460
Study 34522082 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus (40, 50, 60, 70, or 80 µg)
Number of subjects: 40
Study 34522082 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus (70 µg)
Number of subjects: 40
Study 34522082 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus (60 µg)
Number of subjects: 40
Study 34522082 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine IV bolus
Number of subjects: 40
Study 34597388 — intervention group
Group type: EXPERIMENTAL
Intervention: Propionic acid (PA) 500 mg twice daily for 8 weeks
Number of subjects: 0
Study 34597388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33549311 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/mL by PFS × 1 SC injection
Number of subjects: 226
Study 33549311 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg/mL by PFS × 2 SC injections
Number of subjects: 226
Study 33549311 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg/mL by AI × 1 SC injection
Number of subjects: 226
Study 33549311 — intervention group
Group type: COMPARATOR
Intervention: All treatment arms
Number of subjects: 226
Study 33549311 — intervention group
Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg SC delivered by PFS or AI
Number of subjects: 226
Study 34602393 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) administered as intravenous infusion of marrow‐derived autologous MSCs (1×10^6 to 2×10^6/kg) for 8 weeks
Number of subjects: 200
Study 34602393 — intervention group
Group type: COMPARATOR
Intervention: Acetyl cysteine (NACys) 600mg orally twice a day for 8 weeks
Number of subjects: 200
Study 33055247 — intervention group
Group type: EXPERIMENTAL
Intervention: PFMT plus electromyographic biofeedback
Number of subjects: 600
Study 33055247 — intervention group
Group type: COMPARATOR
Intervention: PFMT alone
Number of subjects: 600
Study 34517747 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-stigma reduction programme (psychoeducation, cognitive behavioural therapy and social skills training)
Number of subjects: 278
Study 34517747 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 278
Study 33755548 — intervention group
Group type: EXPERIMENTAL
Intervention: Full assistive technology and telecare package
Number of subjects: 495
Study 33755548 — intervention group
Group type: COMPARATOR
Intervention: Basic assistive technology and telecare package (control)
Number of subjects: 495
Study 34009201 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to wood dust
Number of subjects: 370
Study 34009201 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 370
Study 35961232 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 187
Study 34080313 — intervention group
Group type: EXPERIMENTAL
Intervention: KMRC011 15 μg
Number of subjects: 8
Study 34080313 — intervention group
Group type: EXPERIMENTAL
Intervention: KMRC011 20 μg
Number of subjects: 8
Study 34080313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 34080313 — intervention group
Group type: EXPERIMENTAL
Intervention: KMRC011 (5, 10, 15, and 20 μg)
Number of subjects: 8
Study 34080313 — intervention group
Group type: EXPERIMENTAL
Intervention: KMRC011 (15 μg and 20 μg)
Number of subjects: 8
Study 33928209 — intervention group
Group type: EXPERIMENTAL
Intervention: Study regimen targeting aberrant pathway (veliparib with temozolomide, adavosertib with carboplatin, everolimus, trametinib)
Number of subjects: 69
Study 33928209 — intervention group
Group type: COMPARATOR
Intervention: Control regimen not targeting aberrant pathway (same four regimens as experimental)
Number of subjects: 69
Study 32876128 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS on the dorsomedial prefrontal cortex (DMPFC)
Number of subjects: 14
Study 32876128 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 14
Study 36316875 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Tape (KT) with 50% tension
Number of subjects: 45
Study 36316875 — intervention group
Group type: COMPARATOR
Intervention: Sham group (KT without any tension)
Number of subjects: 45
Study 36316875 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (rigid tape without any tension)
Number of subjects: 45
Study 33886650 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope® Core™ with a hyperangulated blade
Number of subjects: 86
Study 33886650 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐MAC® with a nonangulated Miller blade
Number of subjects: 86
Study 33886650 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Miller laryngoscope
Number of subjects: 86
Study 33886650 — intervention group
Group type: EXPERIMENTAL
Intervention: Glidescope® Core™ with a hyperangulated blade (limited experience)
Number of subjects: 86
Study 33886650 — intervention group
Group type: EXPERIMENTAL
Intervention: Miller laryngoscope (limited experience)
Number of subjects: 86
Study 33886650 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐MAC® Miller (limited experience)
Number of subjects: 86
Study 35973716 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Support Ventilation (ASV)
Number of subjects: 20
Study 34311300 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (PTX) 100 mg/m2 on days 1, 8, 15, 22, 29 and 36 of each 49-day cycle
Number of subjects: 78
Study 34311300 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (DTX) 70 mg/m2 on day 1 of each 21-day cycle
Number of subjects: 78
Study 34311300 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (PTX)
Number of subjects: 78
Study 34311300 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (DTX)
Number of subjects: 78
Study 32992268 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential training (training‐as‐usual plus a one‐session treatment for fear of spiders)
Number of subjects: 28
Study 32992268 — intervention group
Group type: COMPARATOR
Intervention: Training-as-usual
Number of subjects: 28
Study 35409234 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs (paroxetine or sertraline)
Number of subjects: 92
Study 35409234 — intervention group
Group type: EXPERIMENTAL
Intervention: miRNAs
Number of subjects: 92
Study 34684551 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucaloric diet
Number of subjects: 28
Study 34684551 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum diet
Number of subjects: 28
Study 32379631 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 66
Study 32379631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 34417901 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0
Study 34417901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33124759 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient‐Practitioner Orientation Scale (PPOS)
Number of subjects: 321
Study 33124759 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-factor model (sharing and caring dimensions)
Number of subjects: 321
Study 33124759 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal Component Analysis (PCA)
Number of subjects: 321
Study 32175299 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet and fluoride varnish four times a year
Number of subjects: 37
Study 32175299 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet plus six phone call reminders and fluoride varnish four times a year
Number of subjects: 37
Study 32175299 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 37
Study 34470135 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth monitoring
Number of subjects: 214
Study 34470135 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient blood pressure monitoring
Number of subjects: 214
Study 34630601 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 122
Study 34630601 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 122
Study 35870801 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training curriculum with four 15-minute monthly didactics on BHAG and MI followed by VR simulations.
Number of subjects: 55
Study 35870801 — intervention group
Group type: COMPARATOR
Intervention: Control group assessed pediatric respiratory distress with no VR training.
Number of subjects: 55
Study 34464237 — intervention group
Group type: EXPERIMENTAL
Intervention: PES-guided PEEP
Number of subjects: 200
Study 34464237 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP titrated to end-expiratory transpulmonary pressure near 0 cmH2O
Number of subjects: 200
Study 34591702 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based speech perception in noise training for 6 weeks
Number of subjects: 26
Study 34591702 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked text recognition training for 6 weeks
Number of subjects: 26
Study 34591702 — intervention group
Group type: COMPARATOR
Intervention: Computer-based visual training (VT) program
Number of subjects: 26
Study 34047046 — intervention group
Group type: EXPERIMENTAL
Intervention: Osseodensification (OD)
Number of subjects: 56
Study 34047046 — intervention group
Group type: COMPARATOR
Intervention: Subtractive drilling (SD)
Number of subjects: 56
Study 32861110 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynogenetic female Siberian sturgeon (Acipenser baerii)
Number of subjects: 30
Study 32861110 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular analysis based on five microsatellite DNA loci
Number of subjects: 30
Study 35218666 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 669
Study 35218666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 669
Study 34405148 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen (40 gr/d)
Number of subjects: 66
Study 34405148 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen (40 gr/d) plus Fish Oil (10 ml/d)
Number of subjects: 66
Study 34405148 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study 32295574 — intervention group
Group type: EXPERIMENTAL
Intervention: Teachers and student peer-counsellors' attitudes towards abortion and contraceptive use as measured by the SABA and CUS scales.
Number of subjects: 36
Study 32295574 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions (FGDs) conducted with teachers and student peer-counsellors.
Number of subjects: 36
Study 34796725 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency group (26 Hz)
Number of subjects: 78
Study 34796725 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency group (13 Hz)
Number of subjects: 78
Study 34796725 — intervention group
Group type: COMPARATOR
Intervention: Zero-frequency group (0 Hz)
Number of subjects: 78
Study 34796725 — intervention group
Group type: COMPARATOR
Intervention: Berg balance scale
Number of subjects: 78
Study 34796725 — intervention group
Group type: COMPARATOR
Intervention: Walking speed
Number of subjects: 78
Study 32103410 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND (Motivational Interviewing + Behavior Therapy)
Number of subjects: 225
Study 32103410 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 225
Study 35488029 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' BMI at 12 months
Number of subjects: 0